0
‘Epigenetic age’ may help predict lung cancer survival, influence treatment
Harvard T.H. Chan School of Public Health
‘Epigenetic age’ may help predict lung cancer survival, influence treatment | Harvard T.H. Chan School of Public Health
Predicting survival among early-stage non-small cell lung cancer may be improved by considering an individual’s “epigenetic age acceleration”—whether their estimated biological age is older than their actual age—alongside traditional risk factors such as smoking history.
hsph.harvard.edu
0 comments
log in to comment.